EICHORCondition: Metastatic Colorectal Cancer (CRC) · Antineoplastic Agents, Immunological · VEGFR-TKI · Sponsor: Federation Francophone de Cancerologie Digestive
Interested? Contact the study team ↓
Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.
The main objective of this study is to identify the prognostic factors (clinico-biological) for the efficacy (overall survival) of fruquintinib in patients with metastatic colorectal cancer.
This description comes directly from the study's public registry record.
Contact details are listed per location below or on the registry record.
There is no obligation to join — the study team can answer your questions about taking part.
Always discuss trial participation with your own doctor first.
Inclusion Criteria: * Patients aged 18 and over. * Histologically confirmed colorectal adenocarcinoma with locally advanced disease and/or unresectable metastasis(es) receiving treatment with fruquintinib under i) compassionate/early access and ii) marketing authorisation and reimbursement in France. * Obtain informed consent from the patient for the clinical-biological cohort. * Agreement to take biological samples of ctDNA and send tumour blocks (patient participation in the pharmacokinetic study remains optional). Exclusion Criteria: * Patient with another concurrent cancer at the time of diagnosis, requiring systemic treatment or influencing prognosis (in the opinion of the centre's medical team). * Contraindication due to psychological or social reasons that may hinder follow-up (cognitive deficit, psychological disorders incompatible with obtaining consent; inability to be followed in the same centre throughout the follow-up period for geographical reasons). * Pregnant or breast-feeding women. * Patients under court protection or subject to a protective measure (patient under guardianship or curatorship).
Reproduced word-for-word from the public registry record — the study team can answer questions about it.
| Poitiers CHU | Poitiers, France, France | Recruiting |
| Centre Hospitalier | Albi, France | Recruiting |
| CHU | Amiens, France | Recruiting |
| Clinique de L Europe | Amiens, France | Recruiting |
| Centre Hospitalier | Annecy, France | Recruiting |
| Centre Hospitalier | Aurillac, France | Recruiting |
| Centre Hospitalier | Bayeux, France | Recruiting |
| Centre Hospitalier | Bayonne, France | Recruiting |
| Centre Hospitalier | Beauvais, France | Recruiting |
| CHU | Besançon, France | Recruiting |
| Centre Hospitalier Bethune Beuvry | Beuvry, France | Recruiting |
| Centre Pierre Curie | Beuvry, France | Recruiting |
+ 71 more locations — full list on the registry record.
This study lists sites in the areas below. Each link shows other recruiting studies near that city, from the public registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07124858